HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Colorectal Carcinoma

Colorectal carcinoma, also known as colorectal cancer, is a type of cancer that originates in the colon or rectum, both components of the large intestine. It is a significant global health concern and a leading cause of cancer-related morbidity and mortality. This malignancy typically develops from precancerous polyps that form on the inner lining of the colon or rectum. Over time, these polyps may transform into cancerous tumors. Colorectal carcinoma often presents with subtle or nonspecific symptoms in its early stages, making regular screenings and early detection crucial for successful treatment outcomes. Risk factors for colorectal carcinoma include age, family history, genetic predisposition, inflammatory bowel diseases, and certain lifestyle factors such as a high-fat diet, sedentary lifestyle, and smoking. While the exact cause of colorectal cancer remains unclear, a combination of genetic and environmental factors likely contributes to its development. Symptoms may include changes in bowel habits, blood in the stool, abdominal discomfort, unexplained weight loss, and fatigue. Diagnosis typically involves a combination of imaging studies, colonoscopy, and biopsy. Treatment options for colorectal carcinoma depend on the stage of the cancer but often include surgery, chemotherapy, and radiation therapy. Early-stage cancers may be curable with surgical removal, while advanced cases may require a multidisciplinary approach. Preventive measures include adopting a healthy lifestyle, engaging in regular physical activity, maintaining a balanced diet rich in fruits and vegetables, and undergoing recommended screenings, especially for individuals with risk factors or a family history of colorectal cancer. In conclusion, colorectal carcinoma poses a significant health challenge globally. Early detection, combined with advancements in treatment modalities and a focus on prevention, remains key in improving outcomes for individuals affected by this type of cancer.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp